March 3, 2015
REDWOOD CITY, Calif. - March 3, 2015 - HeartFlow Inc., a pioneer in personalized medical technology for cardiovascular disease, has appointed Kent Walker as the newest member of its board of directors. Walker, senior vice president and general counsel at Google, brings extensive knowledge of global technology legal matters, including security and privacy, and corporate governance.
“Kent’s knowledge of the business and legal environment will be of tremendous benefit to HeartFlow, especially as we continue to expand our reach and commercialize the HeartFlow FFRCT® Analysis,” said John H. Stevens, M.D., chairman and CEO of HeartFlow. “His understanding of how to scale large technology companies, while also maintaining data security and privacy, makes him the ideal addition to the board of directors, and we are pleased to incorporate his extensive experience to our board.”
As Google’s general counsel, Walker leads the company’s global legal team and advises its board and management on legal issues and corporate governance matters. Prior to joining Google, Walker held senior legal positions at a number of leading technology companies, including deputy general counsel at eBay Inc., associate general counsel at Netscape and America Online, and senior counsel for AirTouch Communications. Walker started his career as an assistant U.S. attorney with the United States Department of Justice, where he specialized in prosecution of technology crimes and advised the attorney general on management and technology issues.
“HeartFlow has been able to develop and apply advanced technology in a dramatic new way, tackling one of today’s leading health issues,” Walker said. “I look forward to the opportunity to help the organization grow around the world.”
Walker graduated from Harvard College with a bachelor’s degree in social studies, and received his juris doctorate from Stanford Law School. He also serves on the advisory boards of the Harvard School of Public Health and Mercy Corps Social Ventures Fund.
HeartFlow Inc. is a personalized medical technology company dedicated to transforming the way cardiovascular disease is managed. Committed to improving outcomes, reducing costs and creating a better patient experience, HeartFlow’s goal is to provide healthcare professionals with actionable knowledge about each patient by combining best-in-class, non-invasive healthcare imaging with advanced, computational fluid dynamics technology and the insights of big data. Its non-invasive HeartFlow FFRCT Analysis helps physicians diagnose coronary artery disease and provides them with information they need to manage each patient. For more information visit www.heartflow.com.